Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10970310 | Vaccine | 2009 | 6 Pages |
Abstract
Finally, we conclude that, nanoparticle adjuvant IMS 3012 could be a possible alternative to the emulsion adjuvants for primary phase of immunization in antivenom preparation considering its better immunopotentiation capacity and safety in donor animals.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Arun Waghmare, R.L. Deopurkar, Nitin Salvi, Milind Khadilkar, Milind Kalolikar, S.K. Gade,